Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solène M Laville

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Kidney International|November 21, 2025
Untangling causality in nephrology: the example of CKD-MBD and disease progressionSolène M Laville, Sophie Liabeuf
British Journal of Clinical Pharmacology|April 14, 2019
Reply to "Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!" by Stamp et alSolène M Laville, Bénédicte Stengel, Ziad A Massy, et al.
Nephrologie & Therapeutique|March 17, 2026
Putting together the pieces of the care pathway: The French National Health Data system and its applications in nephrologyLéa Faure, Solène M Laville, Latame Komla Adoli, et al.
Annales Pharmaceutiques Francaises|April 5, 2026
[Key Role of the Pharmacist in Collaboration with General Practitioners and Nephrologists in the Management of Chronic Kidney Disease]Sophie Liabeuf, Margot Pauwels, Solène M Laville, et al.
Toxins|September 22, 2022
Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic ReviewMaxime Pluquet, Said Kamel, Gabriel Choukroun, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 17, 2024
Efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients on chronic dialysisSolène M Laville, Cécile Couchoud, Marc Bauwens, et al.
International Journal of Molecular Sciences|July 12, 2025
Transporter-Mediated Interactions Between Uremic Toxins and Drugs: A Hidden Driver of Toxicity in Chronic Kidney DiseasePierre Spicher, François Brazier, Solène M Laville, et al.
Toxins|February 3, 2021
Intestinal Chelators, Sorbants, and Gut-Derived Uremic ToxinsSolène M Laville, Ziad A Massy, Said Kamel, et al.
Arthritis Research & Therapy|November 10, 2019
Acute kidney injury associated with febuxostat and allopurinol: a post-marketing studyAmayelle Rey, Benjamin Batteux, Solène M Laville, et al.
Drug Safety|January 13, 2026
Unveiling the Limits of Anticholinergic Burden Scales: A Study of Adverse Drug Reactions in the French Pharmacovigilance DatabasePauline-Eva Pecquet, Julien Moragny, Valérie Gras, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Kidney International|November 21, 2025
Untangling causality in nephrology: the example of CKD-MBD and disease progressionSolène M Laville, Sophie Liabeuf
British Journal of Clinical Pharmacology|April 14, 2019
Reply to "Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!" by Stamp et alSolène M Laville, Bénédicte Stengel, Ziad A Massy, et al.
Nephrologie & Therapeutique|March 17, 2026
Putting together the pieces of the care pathway: The French National Health Data system and its applications in nephrologyLéa Faure, Solène M Laville, Latame Komla Adoli, et al.
Annales Pharmaceutiques Francaises|April 5, 2026
[Key Role of the Pharmacist in Collaboration with General Practitioners and Nephrologists in the Management of Chronic Kidney Disease]Sophie Liabeuf, Margot Pauwels, Solène M Laville, et al.
Toxins|September 22, 2022
Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic ReviewMaxime Pluquet, Said Kamel, Gabriel Choukroun, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 17, 2024
Efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients on chronic dialysisSolène M Laville, Cécile Couchoud, Marc Bauwens, et al.
International Journal of Molecular Sciences|July 12, 2025
Transporter-Mediated Interactions Between Uremic Toxins and Drugs: A Hidden Driver of Toxicity in Chronic Kidney DiseasePierre Spicher, François Brazier, Solène M Laville, et al.
Toxins|February 3, 2021
Intestinal Chelators, Sorbants, and Gut-Derived Uremic ToxinsSolène M Laville, Ziad A Massy, Said Kamel, et al.
Arthritis Research & Therapy|November 10, 2019
Acute kidney injury associated with febuxostat and allopurinol: a post-marketing studyAmayelle Rey, Benjamin Batteux, Solène M Laville, et al.
Drug Safety|January 13, 2026
Unveiling the Limits of Anticholinergic Burden Scales: A Study of Adverse Drug Reactions in the French Pharmacovigilance DatabasePauline-Eva Pecquet, Julien Moragny, Valérie Gras, et al.
Pageof 5